Delivery Order SPE2DB22D1106-SPE2DB25FEZY7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,984.32, and has an ultimate completion date of July 16, 2025. The contract is not set aside and provides for the delivery of SENSORCAINE-MPF 0.25% VIAL 30ML, a pharmaceutical product. Amerisourcebergen...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, awarded without set-aside provisions through competitive procurement, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contractor will perform the work at its corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,572.83 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on July 18, 2025. This firm fixed-price, non-set-aside contract is structured as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $29,601.60 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price delivery order represents a non-competitive award to the established pharmaceutical distributor and is performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $11,379.98 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $35,404.20 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical products and medical supplies. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a $935,623.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $862,497.87 to AmerisourceBergen Drug Corp on July 26, 2025, for pharmaceutical and medical supply procurement. The contract, which is firm fixed price with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's broader...
- The Defense Logistics Agency Medical Supply Chain awarded a $55,483 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The work will be performed at the contractor's corporate office in Conshohocken,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZY7Delivery Order
The Defense Logistics Agency awarded a $3,629.70 delivery order to AmerisourceBergen Drug Corp on July 27, 2025, for the supply of Sensorcaine-MPF 0.5% vials (30 mL). The contract, which is not set-aside and employs firm fixed pricing, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. Performance is scheduled for completion by July 28, 2025, with work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999.999 billion indefinite delivery vehicle with DLA Troop Support Medical, which extends through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen supplies medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare programs globally. The Sensorcaine-MPF product supplied under this order is a local anesthetic used in medical procedures, consistent with the company's portfolio of critical pharmaceutical products delivered through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/27/25 |